Mouse Anti-LAYN Recombinant Antibody (3F7D7E2) (CBMAB-L0746-YJ)

Liu, C., Wang, Y., Zhang, Y. H., Yuan, Z., Zhang, Z., Zeng, X., ... & Lu, S. (2023). Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status. Immunological Investigations, 52(7), 879-896.

Yang, Y., Chen, Z., Chu, X., Yan, Q., He, J., Guo, Y., ... & Pan, J. (2023). Targeting LAYN inhibits colorectal cancer metastasis and tumor-associated macrophage infiltration induced by hyaluronan oligosaccharides. Matrix Biology, 117, 15-30.

Yang, B., Deng, B., Jiao, X. D., Qin, B. D., Lu, Y., Zhang, W., ... & Zang, Y. S. (2022). Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+ T cells. Cellular Oncology, 45(6), 1297-1309.

Li, L., Ma, H., & Song, C. (2022). LAYN acts as a prognostic biomarker in ovarian cancer by engaging T cell exclusion and dysfunction.

Cao, L., Zhu, L., & Cheng, L. (2022). ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. BioMed Research International, 2022.

Mehta, P., Gouirand, V., Boda, D. P., Zhang, J., Gearty, S. V., Zirak, B., ... & Rosenblum, M. D. (2021). Layilin anchors regulatory T cells in skin. The Journal of Immunology, 207(7), 1763-1775.

Mahuron, K. M., Moreau, J. M., Glasgow, J. E., Boda, D. P., Pauli, M. L., Gouirand, V., ... & Rosenblum, M. D. (2020). Layilin augments integrin activation to promote antitumor immunity. Journal of Experimental Medicine, 217(9).

Pan, J. H., Zhou, H., Cooper, L., Huang, J. L., Zhu, S. B., Zhao, X. X., ... & Rong, L. (2019). LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers. Frontiers in immunology, 10, 6.

Kim, Y., West, G. A., Ray, G., Kessler, S. P., Petrey, A. C., Fiocchi, C., ... & de la Motte, C. A. (2018). Layilin is critical for mediating hyaluronan 35 kDa-induced intestinal epithelial tight junction protein ZO-1 in vitro and in vivo. Matrix Biology, 66, 93-109.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1229)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1227)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1224)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1222)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1228)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1232)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1223)

Mouse Anti-LAYN Recombinant Antibody (AT20G8)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1230)

Mouse Anti-LAYN Recombinant Antibody (CBYJL-1231)

Isotype control